Hong Kong · Delayed Price · Currency is HKD C-MER Medical Holdings Statistics
Total Valuation
HKG:3309 has a market cap or net worth of HKD 992.86 million. The enterprise value is 1.02 billion.
| Market Cap | 992.86M |
| Enterprise Value | 1.02B |
Important Dates
The last earnings date was Tuesday, August 25, 2026.
| Earnings Date | Aug 25, 2026 |
| Ex-Dividend Date | Jun 29, 2026 |
Share Statistics
HKG:3309 has 1.19 billion shares outstanding. The number of shares has decreased by -2.25% in one year.
| Current Share Class | 1.19B |
| Shares Outstanding | 1.19B |
| Shares Change (YoY) | -2.25% |
| Shares Change (QoQ) | -0.67% |
| Owned by Insiders (%) | 2.14% |
| Owned by Institutions (%) | 2.59% |
| Float | 483.41M |
Valuation Ratios
The trailing PE ratio is 9.92.
| PE Ratio | 9.92 |
| Forward PE | n/a |
| PS Ratio | 0.49 |
| PB Ratio | 0.50 |
| P/TBV Ratio | 0.94 |
| P/FCF Ratio | 3.13 |
| P/OCF Ratio | 2.52 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 2.68, with an EV/FCF ratio of 3.23.
| EV / Earnings | 10.19 |
| EV / Sales | 0.50 |
| EV / EBITDA | 2.68 |
| EV / EBIT | 6.10 |
| EV / FCF | 3.23 |
Financial Position
The company has a current ratio of 1.40, with a Debt / Equity ratio of 0.22.
| Current Ratio | 1.40 |
| Quick Ratio | 1.19 |
| Debt / Equity | 0.22 |
| Debt / EBITDA | 1.14 |
| Debt / FCF | 1.37 |
| Interest Coverage | 7.99 |
Financial Efficiency
Return on equity (ROE) is 5.70% and return on invested capital (ROIC) is 6.23%.
| Return on Equity (ROE) | 5.70% |
| Return on Assets (ROA) | 3.71% |
| Return on Invested Capital (ROIC) | 6.23% |
| Return on Capital Employed (ROCE) | 7.17% |
| Weighted Average Cost of Capital (WACC) | 6.00% |
| Revenue Per Employee | 921,281 |
| Profits Per Employee | 45,656 |
| Employee Count | 2,200 |
| Asset Turnover | 0.72 |
| Inventory Turnover | 24.44 |
Taxes
In the past 12 months, HKG:3309 has paid 49.07 million in taxes.
| Income Tax | 49.07M |
| Effective Tax Rate | 30.46% |
Stock Price Statistics
The stock price has decreased by -57.18% in the last 52 weeks. The beta is 0.53, so HKG:3309's price volatility has been lower than the market average.
| Beta (5Y) | 0.53 |
| 52-Week Price Change | -57.18% |
| 50-Day Moving Average | 0.88 |
| 200-Day Moving Average | 1.23 |
| Relative Strength Index (RSI) | 46.40 |
| Average Volume (20 Days) | 395,207 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HKG:3309 had revenue of HKD 2.03 billion and earned 100.44 million in profits. Earnings per share was 0.08.
| Revenue | 2.03B |
| Gross Profit | 633.13M |
| Operating Income | 167.09M |
| Pretax Income | 161.11M |
| Net Income | 100.44M |
| EBITDA | 240.97M |
| EBIT | 167.09M |
| Earnings Per Share (EPS) | 0.08 |
Balance Sheet
The company has 563.37 million in cash and 433.61 million in debt, with a net cash position of 129.76 million or 0.11 per share.
| Cash & Cash Equivalents | 563.37M |
| Total Debt | 433.61M |
| Net Cash | 129.76M |
| Net Cash Per Share | 0.11 |
| Equity (Book Value) | 2.00B |
| Book Value Per Share | 1.54 |
| Working Capital | 213.94M |
Cash Flow
In the last 12 months, operating cash flow was 393.78 million and capital expenditures -77.00 million, giving a free cash flow of 316.78 million.
| Operating Cash Flow | 393.78M |
| Capital Expenditures | -77.00M |
| Depreciation & Amortization | 73.88M |
| Net Borrowing | -121.23M |
| Free Cash Flow | 316.78M |
| FCF Per Share | 0.27 |
Margins
Gross margin is 31.24%, with operating and profit margins of 8.24% and 4.96%.
| Gross Margin | 31.24% |
| Operating Margin | 8.24% |
| Pretax Margin | 7.95% |
| Profit Margin | 4.96% |
| EBITDA Margin | 11.89% |
| EBIT Margin | 8.24% |
| FCF Margin | 15.63% |
Dividends & Yields
This stock pays an annual dividend of 0.02, which amounts to a dividend yield of 2.40%.
| Dividend Per Share | 0.02 |
| Dividend Yield | 2.40% |
| Dividend Growth (YoY) | 50.00% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 28.75% |
| FCF Payout Ratio | n/a |
| Buyback Yield | 2.25% |
| Shareholder Yield | 4.64% |
| Earnings Yield | 10.12% |
| FCF Yield | 31.91% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
HKG:3309 has an Altman Z-Score of 2.33 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.33 |
| Piotroski F-Score | 6 |